Modified tectonic keratoplasty with minimal corneal graft for corneal perforation in severe Stevens - Johnson syndrome: a case series study by unknown
Wang et al. BMC Ophthalmology 2014, 14:97
http://www.biomedcentral.com/1471-2415/14/97RESEARCH ARTICLE Open AccessModified tectonic keratoplasty with minimal
corneal graft for corneal perforation in severe
Stevens - Johnson syndrome: a case series study
Fuhua Wang, Suxia Li, Ting Wang, Hua Gao and Weiyun Shi*Abstract
Background: Corneal perforation in severe Stevens-Johnson syndrome (SJS) presenting great therapeutic difficulties,
the imperative corneal transplantation always result in graft failure and repeated recurrence of perforation. The aim of
this study was to evaluate the effectiveness of a modified small tectonic keratoplasty (MSTK) with minimal corneal graft
in the management of refractory corneal perforation in severe SJS.
Methods: Refractory corneal perforations in ten patients (10 eyes) with severe SJS were mended with a minimal
corneal patch graft, under the guidance of anterior chamber optical coherence tomography, combined with
conjunctival flap covering. The outcome measures included healing of the corneal perforation, survival of the corneal
graft and conjunctival flap, relevant complications, and improvement in visual acuity.
Results: Corneal perforation healed, and global integrity was achieved in all eyes. No immune rejection or graft
melting was detected. Retraction of conjunctival flap occurred in one eye, which was treated with additional
procedure. Visual acuity improved in six eyes (60%), unchanged in three eyes (30%) and declined in one eye (10%).
Conclusions: The MSTK combined with conjunctival flap covering seems to be effective for refractory corneal
perforation in severe SJS.
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Severe Stevens-Johnson syndrome (SJS) usually affects the
eyes with extensive area of necrosis of the ocular surface,
which could result in corneal ulcer or even perforation
[1-3]. Because of severe dry eye, limbal stem cell defi-
ciency, persistent inflammation, trichiasis and symble-
pharon that result from the ocular surface cicatrization
[4,5], corneal perforation in these patients is usually
refractory. Amniotic membrane transplantation (AMT),
conjunctival flaps, and bandage contact lens seems does
not work well [6-8]. In most cases, corneal transplantation
has to be resort to for tectonic reasons.
Orthotopic corneal transplantation is commonly used
in treating corneal perforation. But in eyes with severe
ocular surface disorders, persistent epithelial defects can
lead to graft melting, repeated recurrence of perforation* Correspondence: weiyunshi@163.com
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unless otherwise stated.or even loss of vision [9]. Even though temporary suc-
cess can be achieved in a few cases, long-term immuno-
suppressive drug administration has to be dependent on,
and the graft still faces the risk of failure and other post-
operative complications following orthotopic penetrating
keratoplasty [1,10]. Hence, preservation of the globe is
the main objective of corneal transplantation for severe
SJS, and visual rehabilitation becomes an important but
secondary objective.
Small corneal graft has been successfully used in trea-
ting peripheral corneal perforations as it faces less risks
of graft failure [11-14]. Portnoy et al. mentioned in a
review that an appropriate size corneal graft could be
used to patch the corneal lesions, and then the graft was
covered with a conjunctival flap. But no details of the
technique was described, and the long-term results were
uncertain [15]. In severe dry eye, small grafts still face
the challenge of melting and recurrence of corneal
perforation [12]. To further facilitate survival of smalltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the management of corneal perforation in eyes with se-
vere SJS, we contrived to minimize the size of corneal
graft and a conjunctival flap was used in a combined
procedure. We report here our first experience in a
small series of cases.
Methods
Patients
The study was approved by the Institutional Review
Board of Shandong Eye Hospital and was conducted in
accordance with the principles of the Declaration of
Helsinki. Possible benefits and risks were explained to
all patients, and informed consent was obtained.
The medical records of ten patients (10 eyes), with re-
fractory corneal perforations resulting from severe SJS,
who were treated with modified small tectonic kerato-
plasty (MSTK) combined with conjunctival flap covering
were retrospectively reviewed. All the perforations were
conducted at Shandong Eye Hospital of Shandong Eye In-
stitute between July 2008 and June 2011. The diagnosis of
SJS was mainly based on a history of severe inflammation
of the oral, dermal, and tracheal mucous membranes after
taking medicine or having an infection [16]. Corneal per-
forations were confirmed by fluorescent stream tests. The
size of corneal perforations and the surrounding corneal
lesions was measured by slit-lamp microscopy or high-
definition optical coherence tomography (HD-OCT, Carl
Zeiss AG, Dublin, USA). All eyes underwent corneal scra-
ping with care under a surgical microscope and topical
anesthesia. The biopsy specimens were gram stained and
examined under a microscope for possible bacterial and
fungal infections. As aqueous leakage could disturb the re-
sults of the Schirmer test, it was performed on the fellow
eye in all patients. Localization of corneal perforation,
synechiae, flat anterior chamber, and visual acuity before
surgery were also recorded.Figure 1 Determination of trephine diameter. (A) The appearance of th
Shape of the corneal ulcer (*) and the area with the remaining stroma mor
and overall appearance. The diameter of the trephine should equal to thatAll the patients were immediately administered with
ofloxacin eyedrops (Santen, Osaka, Japan) twice per hour
at the first presentation. Combined MSTK and conjunc-
tival flap covering was performed within 24 hours. The
resected tissues were subjected for etiological examination.
Surgical procedure
Corneal trephination
The trephine size was determined as 1.0 mm larger than
that of the corneal perforation according to the surgeon’s
experience for the first two patients. From the third pa-
tient, HD-OCT was used to minimize the size of corneal
trephine just as illustrated in Figure 1. An area of the
corneal lesions, in which the remaining stroma was at
least 2/3 of the corneal thickness, was firstly marked out.
The trephine diameter was then determined correspon-
ding to the shortest path across the marked area.
Recipients
All surgery was performed under retrobulbar anesthesia
by the same surgeon. Necrotic tissues were cleared from
the surface of the corneal ulcer. Viscoelastic materials
were then injected from the perforation (or, in cases with
synechiae, from a corneal paracentesis at the opposite
side of the perforation) to maintain the anterior chamber
at a safe depth. Meanwhile, the iris incarcerated in the
perforation was restored (Figure 2A and A’). The corneal
trephine was used to mark around the perforation, and
the tissues within the mark were then removed using a
diamond blade (Figure 2B and B’). The posterior stroma
and Descemet’s membrane were reserved under the pre-
condition that necrotic tissues were completely removed
(Figure 2C and C’).
Corneal grafts
A full-thickness corneal button was obtained from a
cryopreserved donor cornea using a corneal trephinee corneal ulcer and perforation on HD-OCT examination. (B and C)
e than two-thirds of the cornea in thickness (†) in the corneal section
of “†”.
Figure 2 The procedure of modified small tectonic keratoplasty and conjunctival flap covering. (A and A’) Corneal ulcer after clearing of
necrotic tissues and restoring of synechia. (B and B’) A selected trephine was used to mark around the perforation. (C and C’) The recipient bed with
the posterior stroma and Descemet’s membrane reserved. (D and D’) The corneal button was placed in the bed and sutured with interrupted 10–0
nylon sutures. (E and E’) A bridge-like conjunctival flap, 0.5 mm larger than the ulcer, was obtained. (F and F’) conjunctival flap was secured tightly
using 10–0 monofilament nylon sutures.
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was ≤3 mm) or 0.25 mm larger than (when the recipient
bed was >3 mm) the recipient bed (Table 1). The donor
button was fixed to recipient with interrupted 10–0 mo-
nofilament nylon sutures (Figure 2D and D’).
Conjunctival flaps
The bulbar conjunctiva near corneal lesions with good
elasticity and rich blood vessels was selected as the
donor site of conjunctival flap. After subconjunctival
injection of 0.5 to 1 mL of 2% lidocaine hydrochloride, a
double pedicle conjunctival flap, 1 mm wider than the
corneal lesion, was obtained 2 mm away from the limbus
(Figure 2E and E’). A thin fascia under the conjunctival
flap was preserved to avoid injury to conjunctival vessels
during separation. Meanwhile, the preserved fascia may
also promote tight adhesion of the conjunctival flap to
corneal lesions. The conjunctival flap was fully separated
toward both ends until it could be pulled to the corneal
lesions without tension, and the eyeball could move
freely towards all directions. Finally, the conjunctival flap
was rotated to cover the entire corneal lesions. A 10–0
monofilament nylon suture was used to secure the flap
with a certain tension (Figure 2F and F’). Any effusion
beneath the conjunctival flap should be drive out with amuscle hook so that the flap could closely attach to cor-
neal lesions.
Postoperative treatment and follow-up
Postoperatively, all patients were given intravenous hy-
drocortisone (2 mg/kg) daily for 3 days. TobraDex eye-
drops (Alcon, Fort Worth, TX) and 1% cyclosporine
A (North China Pharmaceutical Group, Shijiazhuang,
China) were administered four times daily for the first
month and tapered thereafter. Preservative-free artificial
tears were administered 6 ~ 8 times daily according to
the ocular surface conditions.
The patients were followed up weekly for 4 weeks and
monthly or bimonthly thereafter. Visual acuity, slit lamp
appearance, and intraocular pressure (IOP) were eva-
luated. All complications were recorded and disposed.
Surgical success was defined as healing of the ulcer and
perforation, and survival of the conjunctival and corneal
grafts. Failure was defined as corneal graft melting,
recurrence of an ulcer or perforation in the original
position.
Statistical analysis
SPSS 16.0 was used for statistical analysis. The change in
BCVA was analyzed using the Wilcoxon signed-rank
Table 1 Patient demographics, pre- and postoperative data, and follow-up
Patient number 1 2 3 4 5 6 7 8 9 10
Sex/age (years) F/48 M/65 M/42 F/54 M/47 M/61 M/54 F/37 F/58 M/22
Schirmer test (mm) 0 1 1 0 1 3 1 2 0 0
















Activity of SJS Inactive Active Active Active Active Inactive Inactive Active Inactive Active
Prior corneal surgical
procedures (times)
AMT(2), CP (1) CP (2) AMT(1), CP (1) CP (1) CP(1), AMT(1) AMT(1), LK (3) LK (2), PK (1) CP (2) AMT(1), CP(1) AMT(1)
Size of corneal lesion (mm) 4.0 × 5.5 6.0 × 7.5 4.5 × 7.0 4.5 × 5.75 5.0 × 6.0 3.5 × 5.0 3.0 × 5.5 3.5 × 5.75 4.0 × 6.5 3.25 × 4.0
Size of perforation (mm) 2.5 3.5 3.0 2.5 2.5 2.0 2.5 2.5 3.0 2.0
Size of corneal graft (mm) 3.75 4.75 4.25 3.75 4.0 3. 5 3.0 3.5 4.0 3.0
Follow-up (months) 38 34 32 32 20 15 14 11 9 6
Preoperative BCVA 20/200 HM/10 cm CF/10 cm 20/60 HM/50 cm CF/10 cm HM/30 cm 20/100 CF/20 cm 20/200
Final BCVA 20/200 20/50 20/100 20/40 HM/30 cm CF/30 cm HM/30 cm 20/100 20/200 20/100
Preoperative IOP (mmHg) 5 3 8 3 5 4 11 7 4 8
Final IOP (mmHg) 12 13 16 10 12 19 17 11 15 13
F = Female; M =Male; AMT = Amniotic Membrane Transplantation; CP = Conjunctival Flap; LK = lamellar Keratoplasty; PK = Penetrating Keratoplasty; PC = Paracentral; CT = Central; PP = Peripheral; BCVA = best-corrected
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cally significant.
Results
The patients were 4 females (40%) and 6 males (60%), with
an average age of 48.8 years (range, 22–65 years). The
maximum size of each corneal perforation ranged from
2.0 mm to 4.0 mm. There was an irregular corneal ul-
ceration with the outer diameter of 4.0 mm to 7.5 mm
around all the perforations (Figure 3A). All the patients
had been treated with multiple drugs consisting mainly of
local antibiotics and artificial tears, and systemic antibi-
otics before referred to our institution. Also, conjunctival
flap, AMT, penetrating keratoplasty (PK) or/and lamellar
keratoplasty had been performed in other hospitals. The
clinical characteristics of the patients are summarized in
Table 1.
The mean follow-up period was 21.1 ± 11.8 (SD) months
(range, 6 to 38 months). Corneal perforations were healed,
and the integrity of the globes was restored in all patients
(Table 1). No pathogens were detected in any of the cor-
neal scrapings for bacterial and fungal culture.
Conjunctival flaps
The conjunctival flap showed good adhesion to corneal
lesions in 9 patients (patients 1–5, 7–10) during the
follow-up period. A progressive regression of conjunc-
tival flap was observed at 1 month after surgery, and the
conjunctival flap became semi-transparent when healing
of the corneal lesions was completed (Figure 3B). In one
patient (patient 6), the conjunctival flap slipped off the
corneal lesion and was difficult to be reset to the corneal
surface because of poor flexibility associated with an
anamnesis of ocular alkali burn. To promote corneal
epithelial repair and prevent corneal graft autolysis,
conjunctival flap resuture combined with tarsorrhaphy
was performed. The corneal lesions were then healed
completely.Figure 3 Preoperative and postoperative corneal perforation in
patient 2. (A) Preoperatively, the size of the maximum diameter
(blue) of the corneal ulcer was much larger than that of the
minimum diameter(yellow) of the area that a corneal transplantation
could be easily performed. (B) The corneal perforation healed and
the conjunctival flap presented significant regression 6 months
after surgery.Corneal grafts
The corneal grafts presented mild edema within the first
month and became semi-transparent ever since (Figure 3B).
No immune rejection and autolysis occurred in any of the
patients. A corneal ulcer, 2 mm in diameter, occurred just
beside the conjunctival flap in patient 1 at 6 months
(Figure 4A). Another conjunctival flap procedure was
performed after 1 week of ineffective drug therapy. The
perforations healed, and the corneal graft remained stable
in the next 32 months follow-up (Figure 4B).
Visual outcomes and IOP
Visual acuity was improved in 6 eyes (60%), unchanged
in 3 eyes (30%), and declined in one eye (10%) at the
final follow-up. There was a significant difference bet-
ween the preoperative and postoperative visual acuities
(P = 0.043). The IOP of all the patients was within the
normal range throughout the study period.
Discussion
Because of prolonged ocular surface morbidities, corneal
perforations in severe SJS still face great challenge of re-
currence, and the final visual function is always pessimis-
tic. In this series of 10 patients, the corneal perforations
were successfully repaired with MSTK and conjunctival
flap in 9 patients. Tarsorrhaphy was required for remedial
reason in one patient with conjunctival flap failure to ad-
here to the corneal lesion. All corneal grafts remained
stable during the follow-up of no less than 1 year, and im-
proved vision was acquired in more than 50% of the cases.
Efficacy of AMT in treating small corneal perforation
has been well established but unable to promote corneal
stability in patients with severe corneal thinning [17].
Also, because the amniotic membrane cannot control cor-
neal melting effectively in dry eyes [18], it does not seem
to work well in patients with SJS [6,10], which was further
confirmed in 6 patients in this study. Conjunctival flaps
could be used for small eccentric corneal perforations [1],
but could not seal large corneal perforations associatedFigure 4 Postoperative corneal perforation in patient 2.
(A) The corneal perforation healed yielding a visual acuity of 20/200
at 6 months after surgery. But a clean, paranasal corneal ulcer, 2 mm
in diameter, occurred just beside the conjunctival flap. (B) Both the
corneal ulcer and the perforation healed with good survival of the
corneal graft and conjunctival flap at 32 months after the second
surgery.
Wang et al. BMC Ophthalmology 2014, 14:97 Page 6 of 7
http://www.biomedcentral.com/1471-2415/14/97with corneal melting because the leap would continue
under the flap [19,20]. Things were the same for 7 patients
in this study. Tissue adhesives are effective for corneal
perforations in a diameter of less than 2 mm but not for
those chronic, deep ulcers, and the toxicity may worsen
inflammatory reaction [21].
Traditional orthotopic PK, using a large-diameter
graft, could achieve comparable anatomical and func-
tional success in treating corneal perforation. But in pa-
tients with severe SJS, the corneal grafts are facing high
risk of immune rejection, persistent epithelial defection,
infection, graft melting, and resultant recurrence of cor-
neal perforation [22]. Tugal-Tutkun et al. reported PK,
with grafts of 7.5 mm to 14 mm, for cicatrizing conjunc-
tival diseases in 13 eyes, among which three out of four
grafts in patients with SJS failed and required additional
procedures [9]. Theoretically, the smaller the size of a
corneal graft, the greater is the chance of its survival.
Soong et al. reported 3 cases of fistulous wound leaks
after cataract surgery successfully treated with small
diameter corneal grafts for tectonic reasons [11]. Similar
procedures were performed by Chern in treating various
peripheral corneal disorders with small-diameter, round,
eccentric PK [12]. We previously modified this tech-
nique by preserving the deep stroma, Descemet’s mem-
brane, and the endothelium of the corneal bed as much
as possible, so that glycerin-cryopreserved grafts could
be used with ultimate transparency [13]. But all the cor-
neal grafts used in the reported cases had the same size
as corneal lesions, and all the eyes had a relative fertile
ocular surface. The single case with ocular surface
disorder reported by Chern et al. developed epithelial
keratopathy and required further treatment [12]. In this
study, two patients had been treated with repeated small
corneal graft transplantation, but both failed in graft
melting and recurrence of corneal lesions. Therefore,
small corneal grafts in patients with severe ocular dis-
orders still risk graft failure.
Corneal perforations in SJS are usually developed from
corneal melting, and there is commonly an irregular cor-
neal lesion, much larger than corneal perforation, which is
usually apparent on HD-OCT examination (Figure 1A). If
corneal grafts are prepared according to the corneal ulcer,
certainly much larger than the perforation, the risk of graft
failure would inevitably increase. In view of the character-
istics of corneal perforation in SJS, we hypothesized that
the diameter of corneal graft could be further reduced just
to repair the perforation. In our experience, grafts can be
well sutured as long as the thickness of the edge of the
recipient bed is more than two-thirds of the cornea.
Hence, instead of trying to cover the entire ulcer, we se-
lected a trephine according to the shortest path through
the central ulcer in which the remaining stromal thickness
was more than two-thirds of the cornea (Figure 1Band C). In this study, all the 10 corneal grafts were suc-
cessfully transplanted to the recipients, which indicate the
feasibility of corneal transplantation with a reduced-size
corneal graft.
Due to the fact that the corneal graft was much smal-
ler than the ulcer, a ‘ditch’ was left around the graft
(Figure 1C*). The epithelium of the recipient was expected
to step across the ditch to cover the graft, which was a dif-
ficult task in the eye with severe ocular surface disorder.
To prevent secondary infection and to enable repair of the
ditch between the graft and the corneal bed, an effective
epithelial barrier must be provided. Also, a sufficient
source of nutrients was necessary to ensure the survival of
corneal graft. AMT, with the function of promoting epi-
thelialization and decreasing inflammation, neovasculari-
zation and fibrosis [17], was a potential selection. But its
function would disappear with the amniotic membrane
melting within one month after transplantation. Tarsor-
rhaphy could improve re-epithelialization and prevent
corneal melting [23], but it is not acceptable for most pa-
tients for poor cosmetic appearance. Moreover, it could
interfere with the observation of corneal lesions. So tarsor-
rhaphy was selected only when there were no other
choices. Conjunctival flap, rich in blood vessels, is effective
in treating refractory corneal ulcers. Although cosmetic
appearance was poor over a period of time after surgery,
the conjunctival flap would have a marked regression after
healing of corneal lesions [24], and there is not any diffe-
rence between conjunctival flap blood vessels and corneal
neovascular results from severe SJS. Ultimately, the cos-
metic appearance and impairment of corneal clarity after
conjunctival flap covering are acceptable for most patients.
Therefore, in this study, conjunctival flap was used for
protective reasons. No one complained about the cos-
metic appearance of conjunctival flap.
In this case series, MSTK combined with conjunctival
flap achieved favorable effects. The success of this com-
bined procedure may be attributed to the following as-
pects. First, the corneal graft was quite small, which
resulted in a lower risk of immune rejection and melt-
ing. Second, the corneal graft restored the integrity of
the eye and added a rigid barrier between the aqueous
humor and the conjunctival flap, which facilitated adhe-
rence of conjunctival flap to the corneal lesions. Third,
the conjunctival flap helped to prevent secondary infec-
tion by covering the space around the small-diameter
corneal graft. Fourth, the flap aided in the absorption of
necrotic tissues and promoted vascularization of the
wounded cornea [24], thus preventing graft melting and
the extension of remaining ulcers. In the only case with
conjunctival flap failure, corneal epithelial reconstruction
was delayed, and an additional procedure was required,
which indicates the importance of conjunctival flap in
this combined procedure.
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most patients may have poor visual acuity after treat-
ment, and additional treatment for improving eyesight
can be performed. Moreover, conjunctival flaps could
not be obtained for protective necessities in patients
who do not have enough healthy conjunctivas. Hence,
permanent tarsorrhaphy would eventually be resorted to.
Conclusion
In summary, combined MSTK and conjunctival flap co-
vering is effective in treating corneal perforations in SJS.
The eye globe could achieve tectonic integrity with a mini-
mal corneal allograft under the protection of conjunctival
flap, and the vision could be partly restored. This com-
bined procedure might also be considered for the treat-
ment of refractory corneal perforations associated with
other severe systemic immune diseases.
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